Financials data is unavailable for this security.
View more
Year on year Deversify Health AB (publ) had revenues fall -31.53% from 27.26m to 18.66m, though the company grew net income from a loss of 23.26m to a smaller loss of 21.16m.
Gross margin | 114.37% |
---|---|
Net profit margin | -88.80% |
Operating margin | -86.96% |
Return on assets | -124.86% |
---|---|
Return on equity | -317.41% |
Return on investment | -188.09% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at Deversify Health AB (publ) fell by 2.52m. Cash Flow from Financing totalled 2.34m or 12.54% of revenues. In addition the company used 4.02m for operations while cash used for investing totalled 847.00k.
Cash flow per share | -0.0778 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0648 |
---|---|
Tangible book value per share | -0.0648 |
More ▼
Balance sheet in SEKView more
Current ratio | 0.1601 |
---|---|
Quick ratio | 0.1601 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼
Growth rates in SEK
Year on year, growth in earnings per share excluding extraordinary items increased 21.11%.
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 12.41 |